NeurosciencebioRxivPreprint
Sub-clinical glutamate receptor antagonist combinations prevent progressive demyelination.
Verity F. T. Mitchener, Chris Bulman, Alexander Mellor…·Robert F. Fern
The paper shows that sub-clinical doses of NMDA and AMPA glutamate receptor antagonists protect against demyelination in experimental models of multiple sclerosis.
1 citation